Eli Lilly hits new all-time high buoyed by recent drug approvals; up 21% YTD (NYSE:LLY)
Eli Lilly (LLY), already one of the best performing large pharma stocks year to date, hit an all-time high of $332.67 on Wednesday morning. YTD, the stock is up ~21%.
Eli Lilly hits new all-time high buoyed by recent drug approvals; up 21% YTD (NYSE:LLY)
Eli Lilly (LLY), already one of the best performing large pharma stocks year to date, hit an all-time high of $332.67 on Wednesday morning. YTD, the stock is up ~21%.